Target Price | $45.90 |
Price | $25.92 |
Potential |
77.08%
register free of charge
|
Number of Estimates | 18 |
18 Analysts have issued a price target IDEAYA Biosciences Inc 2026 .
The average IDEAYA Biosciences Inc target price is $45.90.
This is
77.08%
register free of charge
$67.20
159.26%
register free of charge
$27.27
5.21%
register free of charge
|
|
A rating was issued by 22 analysts: 19 Analysts recommend IDEAYA Biosciences Inc to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the IDEAYA Biosciences Inc stock has an average upside potential 2026 of
77.08%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 7.00 | 11.44 |
70.07% | 63.41% | |
EBITDA Margin | -4,637.00% | -2,798.43% |
721.97% | 39.65% | |
Net Margin | -3,921.14% | -2,646.41% |
711.93% | 32.51% |
20 Analysts have issued a sales forecast IDEAYA Biosciences Inc 2025 . The average IDEAYA Biosciences Inc sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an IDEAYA Biosciences Inc EBITDA forecast 2025. The average IDEAYA Biosciences Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
17 IDEAYA Biosciences Inc Analysts have issued a net profit forecast 2025. The average IDEAYA Biosciences Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.36 | -3.45 |
71.43% | 2.68% | |
P/E | negative | |
EV/Sales | 140.05 |
17 Analysts have issued a IDEAYA Biosciences Inc forecast for earnings per share. The average IDEAYA Biosciences Inc EPS is
This results in the following potential growth metrics and future valuations:
IDEAYA Biosciences Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
Guggenheim |
Locked
➜
Locked
|
Locked | Sep 18 2025 |
Mizuho |
Locked
➜
Locked
|
Locked | Sep 12 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Sep 09 2025 |
Stephens & Co. |
Locked
➜
Locked
|
Locked | Sep 09 2025 |
Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Sep 09 2025 |
JMP Securities |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
JMP Securities |
Locked
➜
Locked
|
Locked | Sep 04 2025 |
Analyst Rating | Date |
---|---|
Locked
Guggenheim:
Locked
➜
Locked
|
Sep 18 2025 |
Locked
Mizuho:
Locked
➜
Locked
|
Sep 12 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Sep 09 2025 |
Locked
Stephens & Co.:
Locked
➜
Locked
|
Sep 09 2025 |
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Sep 09 2025 |
Locked
JMP Securities:
Locked
➜
Locked
|
Sep 08 2025 |
Locked
JMP Securities:
Locked
➜
Locked
|
Sep 04 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.